Evidence map›Paper›PMID 35040030›Full record

ArticleJournal of fluorescence2022

Synthesis and Investigation of Derivatives of 1,8-Naphthalimide with a Red Emission via an Aromatic Nucleophilic Substitution Reaction.

Chul-Hyun Jeong, Aatiya Ahmad, Hannah C Schmitz, Haishi Cao

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of fluorescence, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chul-Hyun JeongDepartment of Chemistry, University of Nebraska-Kearney, Kearney, NE, US, 68849.
Aatiya AhmadDepartment of Chemistry, University of Nebraska-Kearney, Kearney, NE, US, 68849.
Hannah C SchmitzDepartment of Chemistry, University of Nebraska-Kearney, Kearney, NE, US, 68849.
Haishi CaoDepartment of Chemistry, University of Nebraska-Kearney, Kearney, NE, US, 68849. caoh1@unk.edu.ORCID http://orcid.org/0000-0002-6789-0998

Funding

UNMC Structural Biology CoreP20GM103427 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI PAUL L SORGEN · 2012 to 2026
$59.2M
ZINC FINGER-INSPIRED FLUORESCENT CHEMOSENSORSP20RR016469 · NCRR · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI EUDY, JAMES D · 2001 to 2011
$36.2M
NCRR NIH HHS 5P20RR016469NCRR NIH HHS P20 RR016469NIGMS NIH HHS INBRE-8P20GM103427NIGMS NIH HHS P20 GM103427
6 · The paper itself

Abstract

1,8-Napthalimides (NIs) have been widely used as fluorescent molecules in biological, chemical, and medical fields because NIs shows high stability and various fluorescence properties under different conditions. However, NIs typically display a fluorescence emission wavelength in the range of 350 - 550 nm which can be notably interfered with by autofluorescence in living cells, significantly limiting their bio-applications. Moreover, low solubility in aqueous media is another major limitation for NIs. In this project, four derivatives of NIs (1-4) have been synthesized via an aromatic nucleophilic substitution reaction and their photophysical properties have been investigated in various media (water, MeOH, MeCN, DMSO, EtOAc, and THF). All of these derivatives (1-4) show a long emission wavelength around 600 nm and high solubility in polar solvents. Particularly molecules (1-4) show the longest emission (624-629 nm) in water and the fluorescence intensity is not significantly varied in the range of pH 4-11. These unique features, long emission wavelength, high solubility, and high stability in difference pH media, will allow these derivative (1-4) to be used as excellent labeling reagents in the biological system.

Indexed as

1,8-naphthalimideFluorescenceLong emissionMalononitrile

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.